NSE filing, NSE: LUPIN. Summary written from the filing by ALFA Finder's alert engine.
Lupin Ltd: key numbers
- Share price
- ₹1,950.00
- Market cap
- ₹89,172 Cr
- Revenue (annual)
- ₹27,958 Cr
- Net profit (annual)
- ₹5,333 Cr
- P/E (TTM)
- 17.1×Sector 48.6×
- Promoter holding
- 46.84%-0.01% QoQ
- FII holding
- 23.28%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Lupin Ltd
All →Lupin Product Launch
Lupin announced the European launch of its biosimilar Ranibizumab (Ranluspec) via commercial partner Sandoz. The launch covers Europe excluding Germany following European Commission approval.
Lupin Earnings Call Transcript: Key Takeaways
Revenue up 11% to ₹7,827 Cr, but EBITA margin fell to 25.1% from 31.3%; US down 13.4% QoQ on Tolvaptan erosion; management hedged FY28 outlook.
Lupin Investor Presentation: Key Takeaways
Q2 FY27 net sales ₹77,855mn (+14% YoY); EBITDA ₹19,574mn, margin 25.1% (vs 31.3%); net income ₹11,553mn (-21.8% YoY). US pressured by competition/LOE.
Lupin Management Change
Lupin appointed Akhil Gupta as an Additional and Independent Director effective 3 November 2026, for five years to 2031. The appointment is subject to shareholder approval.
Lupin Q2 FY27 Results: Net Profit ₹1,155 Cr, Down 22.2% YoY
Lupin Ltd reported revenue from operations of ₹7,827 Cr (+11.1% YoY) and net profit of ₹1,155 Cr (-22.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1,155 Cr · -22.2% YoY
Lupin Product Launch
Lupin launched generic Raltegravir Tablets 600 mg in the United States. It is first-to-file, with 180-day exclusivity.
Other annual general meeting announcements
All →Khazanchi Jewellers Annual General Meeting
Khazanchi Jewellers' EGM on November 17, 2026 approved Ms. Simran Lodha's appointment as Independent Director for three years. The resolution was a special resolution passed via e-voting.
Solara Active Pharma Sciences Annual General Meeting
Solara Active Pharma seeks postal ballot approval for revised remuneration of its whole-time director and managing director. E-voting closes 17 December 2026.
Prataap Snacks Annual General Meeting
Prataap Snacks issued a postal ballot notice seeking approval to appoint Jitendra Nayyar and Sumit Sharma as directors and to reclassify some promoter group members as public. Voting ends December 18, 2026.
Sayaji Hotels Annual General Meeting
Sayaji Hotels filed a postal ballot notice seeking shareholder approval to appoint two non-executive non-independent directors. E-voting runs from 18 November to 18 December 2026.
Bliss GVS Pharma Annual General Meeting
Bliss GVS Pharma's postal ballot sought approval to appoint three Non-Executive Non-Independent Directors. The voting results show all three resolutions passed with majority approval.
Coreintegra Consulting Services Annual General Meeting
Coreintegra seeks postal ballot approval to vary IPO fund objects and utilise Rs 15.15 Crore of unutilised proceeds. E-voting runs until 17 December 2026.
- Value
- ₹15.15 Cr
- Execution
- E-voting from 18 November 2026 (09:00 a.m.) to 17 December 2026 (05:00 p.m.)